BRCA2 and breast carcinoma: On the other hand, both of the above-mentioned BRCA2-deficient cases showed the highest number of RS5 rearrangement signatures (Fig. 1a, Supplementary Fig. 11), which were previously described in breast cancer to be strongly associated with the loss of function of BRCA210.